Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
211. |
ECCT/21/07/01 | RESOLVE A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell… read more |
Principal Investigator(s) 1. Bernhards Ragama Ogutu 2. Jessie Nyokabi Githanga Site(s) in Kenya 1. Strathmore University Medical Center (Nairobi City county)… read more |
View |
212. |
ECCT/21/10/02 |
RESOLVE A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease |
Principal Investigator(s) 1. Janet Oyieko Site(s) in Kenya 1. KEMRI CCR- Butere County Hospital (Kisumu county) 2. Strathmore University (Nairobi City… read more |
View |
213. |
ECCT/21/11/06 |
RESOLVE A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease |
Principal Investigator(s) 1. Videlis Nduba Site(s) in Kenya 1. KEMRI/CRDR Siaya Clinical Research Annex (Siaya county) 2. KEMRI CRDR Clinical Research… read more |
View |
214. |
ECCT/24/01/03 |
Doxy Short Course A Phase 4 Study of a 3-Day Vs. 7-Day Regimen of Doxycycline for the Treatment of Chlamydial Infection. |
Principal Investigator(s) 1. Jackson Nyangaresi Nyandoro 2. Nelly Rwamba Mugo Site(s) in Kenya 1. Pwani Research Centre (Mombasa county) 2. KEMRI CCR-PHRD (… read more |
View |
215. |
ECCT/21/07/05 | CARES A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine from… read more |
Principal Investigator(s) 1. Dr Reena Shah Site(s) in Kenya 1. Aga Khan University Hospital Nairobi (Nairobi City county) 2. KEMRI Walter Reed Project (… read more |
View |